Strategies for cancer prevention involving reduction or elimination of human exposure to environmental carcinogens may not always be possible. Inhibition of the development of cancer by the administration of chemicals may offer a practical alternative for reducing human cancer burden. However, the successful utilization of chemoprotective interventions will require solid mechanistic understanding of the action of these agents. The proposed study will investigate the modes of protection afforded by dietary 1, 2- dithiole-3-thiones, reported constituents of cruciferous vegetables, on aflatoxin Beta 1 hepatocarcinogenesis in the rat. Previous studies from our laboratories have demonstrated that dietary antioxidants, including 1, 2-dithiole-3-thiones, block chemical carcinogenesis at this target site. Evidence to date suggests that dietary antioxidants induce the activities of carcinogen detoxication enzymes to result in lower levels of DNA adduct formation and enhanced carcinogen elimination. The proposed will extend these studies by 1) synthesizing a series of rationally-designed analogues of 1, 2- dithiole-3-thione; 2)evaluating the spectrum of actions and mechanisms of these compounds on the induction of Phase I and II enzymes and reduction in carcinogen-DNA adducts; 3) examining the chemoprotective actions of the newly synthesized dithiolthiones as inhibitors of gamma glutamyltranspeptidase positive lesions, a short-term model for aflatoxin carcinogenesis, as well as hepatic cancers; and, 4) utilizing the dithiolthione/aflatoxin chemoprotection model to develop and validate biomarkers for assessing both risk from carcinogen exposure and the efficacy of anticarcinogen intervention. The long term goal of this work is to facilitate our understanding of how dietary constituents may modulate the target organ risk in human populations exposed to naturally-occurring carcinogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039416-07
Application #
3178349
Study Section
Pathology B Study Section (PTHB)
Project Start
1985-09-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Wible, Ryan S; Tran, Quynh T; Fathima, Samreen et al. (2018) Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo. Mol Pharmacol 93:297-308
Johnson, Natalie M; Egner, Patricia A; Baxter, Victoria K et al. (2014) Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res (Phila) 7:658-65
Fasullo, Michael; Smith, Autumn; Egner, Patricia et al. (2014) Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae. Mutat Res Genet Toxicol Environ Mutagen 761:18-26
Kensler, Kevin H; Slocum, Stephen L; Chartoumpekis, Dionysios V et al. (2014) Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice. Toxicol Sci 139:293-300
Kensler, Thomas W; Egner, Patricia A; Agyeman, Abena S et al. (2013) Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163-77
Takaya, Kai; Suzuki, Takafumi; Motohashi, Hozumi et al. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53:817-27
Wogan, Gerald N; Kensler, Thomas W; Groopman, John D (2012) Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 29:249-57
Koissi, Niangoran; Shah, Niti H; Ginevan, Brandon et al. (2012) Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat. Chem Res Toxicol 25:1022-8
Fahey, Jed W; Talalay, Paul; Kensler, Thomas W (2012) Notes from the field: ""green"" chemoprevention as frugal medicine. Cancer Prev Res (Phila) 5:179-88
Kensler, Thomas W; Roebuck, Bill D; Wogan, Gerald N et al. (2011) Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 120 Suppl 1:S28-48

Showing the most recent 10 out of 116 publications